Csequence Insights
Stay Informed and Educated with Csequence’s Blog
Understanding Cannabis Use in Primary Care: Prevalence, Risks, and Clinical Implications
This article highlights the high prevalence of cannabis use among primary care patients and underscores the necessity for routine screening to manage health symptoms and identify risks for cannabis use disorder. Implementing such screenings can enhance patient care by addressing both therapeutic use and potential substance use issues.
Athletes and Marijuana
The controversy continues about athletes and the use of cannabis following the Paris Olympics. This week we celebrate Sha’Carri Richardson’s gold medal and examine both the science and the politics around marijuana and athletic performance.
A Review of Cannabis Use and Mortality Risks: Implications and Findings from a UK Biobank Study
This article is important as it provides critical insights into the potential health risks associated with heavy cannabis use, particularly highlighting the increased cardiovascular disease (CVD) mortality risk among females. These findings underscore the need for gender-specific public health strategies and clinical guidelines to address the growing prevalence of cannabis use.
Comment period ends at the DEA, promising research, and testing lab troubles
DEA comment period ends. GOP lawmakers express doubt about rescheduling marijuana but are out of sync with a majority of Americans. Promising research on cancer treatment and among drug abusers. Watch our Journal Club and read two studies on the reduction of craving among users. The troubles with testing labs continue.
A Review of Cannabis Use and Mortality Risks: Implications and Findings from a UK Biobank Study
This article is important as it provides critical insights into the potential health risks associated with heavy cannabis use, particularly highlighting the increased cardiovascular disease (CVD) mortality risk among females. These findings underscore the need for gender-specific public health strategies and clinical guidelines to address the growing prevalence of cannabis use.
States Rake in Big Bucks, The Federal Governments Steps In and Changes in the Way We Play Ball
This week the Federal government addresses key issues related to testing and clinical research in cannabis. States see impressive revenues from legalization. The NCAA removes marijuana from its banned substances list. States generating big revenue from legalization...
The Hidden Dangers of Edible Cannabis: Analyzing Emergency Department Visits Among Older Adults Post-Legalization in Ontario
This article highlights the significant public health implications of cannabis legalization, particularly for older adults who are at increased risk of adverse effects from cannabis poisoning. By examining the rise in emergency department visits post-legalization, the study underscores the need for targeted safety measures and age-specific guidelines to protect this vulnerable population.
Impact of State Cannabis Legalization on Health Care Encounters Among Older Adults
The article “State Cannabis Legalization and Trends in Cannabis-Related Disorders in US Older Adults, 2017 to 2022” provides a comprehensive analysis of the impact of state-level cannabis legalization on the prevalence of cannabis-related health care encounters among Medicare beneficiaries aged 65 and older. Utilizing a robust dataset spanning five years, the authors effectively characterize how legalization for medical use and recreational use correlates with reported cannabis-related disorders.
Marijuana use the good, the bad, and the weird. The Fed opens public comments on rescheduling.
The federal government solicits public comment on rescheduling marijuana until July 22, 2024. Take a look at people are saying or submit a comment. A round up of studies looking at the benefits of medicinal marijuana and some of the concerns. Comparing the damage of...
The AMA weighs in, debunking the “stoner” stereotype, and the illegal marijuana market
A study out this week from the American Medical Association suggests that consumers use marijuana primarily for health issues. Two studies suggest that the old “stoner” stereotype may be inaccurate. An early phase test in mice suggests that terpenes may be more effective than morphine in pain management. Despite legalization ProPublica reports crime in illegal marijuana sales still flourishes.